165 related articles for article (PubMed ID: 33708397)
1. Competitive cocrystallization and its application in the separation of flavonoids.
Xia Y; Wei Y; Chen H; Qian S; Zhang J; Gao Y
IUCrJ; 2021 Mar; 8(Pt 2):195-207. PubMed ID: 33708397
[TBL] [Abstract][Full Text] [Related]
2. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
4. In Situ Cocrystallization of Dapsone and Caffeine during Fluidized Bed Granulation Processing.
Todaro V; Worku ZA; Cabral LM; Healy AM
AAPS PharmSciTech; 2019 Jan; 20(1):28. PubMed ID: 30603811
[TBL] [Abstract][Full Text] [Related]
5. Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal.
Rodríguez-Ruiz C; Montes-Tolentino P; Domínguez-Chávez JG; Morales-Rojas H; Höpfl H; Herrera-Ruiz D
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214066
[TBL] [Abstract][Full Text] [Related]
6. Molecular Structure, Spectral Investigations, Hydrogen Bonding Interactions and Reactivity-Property Relationship of Caffeine-Citric Acid Cocrystal by Experimental and DFT Approach.
Verma P; Srivastava A; Srivastava K; Tandon P; Shimpi MR
Front Chem; 2021; 9():708538. PubMed ID: 34381761
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
Panzade PS; Shendarkar GR
Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Pharmaceutical Cocrystals: A Focused Review of Flavonoid Cocrystals.
Xu J; Shi Q; Wang Y; Wang Y; Xin J; Cheng J; Li F
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677670
[TBL] [Abstract][Full Text] [Related]
9. Enantioselectivity of chiral dihydromyricetin in multicomponent solid solutions regulated by subtle structural mutation.
Sun J; Wang Y; Tang W; Gong J
IUCrJ; 2023 Mar; 10(Pt 2):164-176. PubMed ID: 36692859
[TBL] [Abstract][Full Text] [Related]
10. Tuning the Pharmacokinetic Performance of Quercetin by Cocrystallization.
Haskins MM; Kavanagh ON; Sanii R; Khorasani S; Chen JM; Zhang ZY; Dai XL; Ren BY; Lu TB; Zaworotko MJ
Cryst Growth Des; 2023 Aug; 23(8):6059-6066. PubMed ID: 37547881
[TBL] [Abstract][Full Text] [Related]
11. Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal.
Aher S; Dhumal R; Mahadik K; Ketolainen J; Paradkar A
Pharm Dev Technol; 2013 Feb; 18(1):55-60. PubMed ID: 21981663
[TBL] [Abstract][Full Text] [Related]
12. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Effects of Solvents on Cocrystallization by Computational Simulation Approach.
Dhibar M; Chakraborty S; Basak S
Curr Drug Deliv; 2021; 18(1):44-53. PubMed ID: 32753012
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Xue N; He B; Jia Y; Yang C; Wang J; Li M
Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
[TBL] [Abstract][Full Text] [Related]
15. Formation of Ciprofloxacin-Isonicotinic Acid Cocrystal Using Mechanochemical Synthesis Routes-An Investigation into Critical Process Parameters.
Karimi-Jafari M; Ziaee A; O'Reilly E; Croker D; Walker G
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336009
[TBL] [Abstract][Full Text] [Related]
16. Cocrystals of quercetin with improved solubility and oral bioavailability.
Smith AJ; Kavuru P; Wojtas L; Zaworotko MJ; Shytle RD
Mol Pharm; 2011 Oct; 8(5):1867-76. PubMed ID: 21846121
[TBL] [Abstract][Full Text] [Related]
17. Flavone Cocrystals: A Comprehensive Approach Integrating Experimental and Virtual Methods.
Petrick TL; Grünwald A; Braun DE
Cryst Growth Des; 2024 May; 24(10):4195-4212. PubMed ID: 38766642
[TBL] [Abstract][Full Text] [Related]
18. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
Shah K; Parmar VK
Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
[TBL] [Abstract][Full Text] [Related]
19. Considerations on high-throughput cocrystals screening by ultrasound assisted cocrystallization and vibrational spectroscopy.
Rodrigues M; Lopes J; Guedes A; Sarraguça J; Sarraguça M
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 229():117876. PubMed ID: 31818645
[TBL] [Abstract][Full Text] [Related]
20. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
Eddleston MD; Madusanka N; Jones W
J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]